Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2010; 104(02): 194-195
DOI: 10.1160/TH09-12-0839
DOI: 10.1160/TH09-12-0839
Editorial Focus
Ischaemic preconditioning and stem cell mobilisation
Financial support: This work was supported by grants from Seed Funding for Basic Research (#10208618 to Q Lian) and Small Project Funding (#10400639, to Q Lian); and HKU Strategic Research Theme on Healthy Ageing (to Q Lian and HF Tse) from the University of Hong Kong.
Further Information
Publication History
Received:
15 December 2009
Accepted:
15 April 2009
Publication Date:
24 November 2017 (online)
-
References
- 1 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia – a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
- 2 Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 2007; 12: 181-188.
- 3 Ii M, Nishimura H, Iwakura A. et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported„ nitric oxide synthase activity. Circulation 2005; 111: 1114-1120.
- 4 Kamota T, Li TS, Morikage N. et al. Ischemic preconditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 2009; 53: 1814-1822.
- 5 Gyongyosi M, Posa A, Pavo N. et al. Differential effect of ischaemic preconditioning on mobilisation and recruitment of hematopoietic and mesenchymal stem cells in porcine myocardial ischaemic-reperfusion. Thromb Haemost 2010; 103: 376-384.
- 6 Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007; 98: 1335-1342.
- 7 Torella D, Ellison GM, Mendez-Ferrer S. et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med 2006; 03 (Suppl. 01) S8-13.
- 8 Egan CG, Caporali F, Huqi AF. et al. Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics. Thromb Hae-most 2009; 101: 1138-1146.
- 9 Timmers L, Lim SK, Arslan F. et al. Reduction of myocardial infarct size by human mesenchymalstem cell conditioned medium. Stem Cell Res 2007; 01: 129-137.
- 10 Gnecchi M, He H, Liang OD. et al. Paracrine action accounts for marked protection of ischemic heart by Aktmodified mesenchymal stem cells. Nat Med 2005; 11: 367-368.
- 11 Tse HF, Zhu SG, Zhang OY. et al. Paracrine effects of direct intramyocardial implantation of bone marrow mononuclear cells to enhance neovascularization in chronic ischernic myocardium. Eur J Heart Fail 2007; 09: 747-753.
- 12 Menasche P. Stem cells for clinical use in cardiovascular medicine. Thromb Haemost 2005; 94: 697-701.
- 13 Tse HF, Thambar S, Kwong YL. et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 2007; 28: 2998-3005.
- 14 Niagara MI, Haider HK, Jiang SJ. et al. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007; 100: 545-555.
- 15 Tang YL, Zhu W, Cheng M. et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009; 104: 1209-1216.